Loading...
Loading...
Caliper Life Sciences shares were surging in premarket trading Thursday on the announcement the company is being bought by PerkinElmer for about $600 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in